Skip to content

Investigative Headgear With CPAP Mask

Investigative Headgear With CPAP Mask

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02323035
Enrollment
23
Registered
2014-12-23
Start date
2014-12-31
Completion date
2016-11-30
Last updated
2019-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

This investigation is designed to evaluate the at-home usability, performance, user acceptance and reliability of the Headgear with a CPAP Mask for a duration of 2-4 weeks.

Detailed description

Up to 300 participants will be recruited for the trial, consisting of male and female participants diagnosed with OSA and receiving CPAP or Bi-level PAP for the treatment of their OSA. These include current CPAP mask users.

Interventions

DEVICEHeadgear

Investigative Headgear with CPAP Mask.

Sponsors

Fisher and Paykel Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* AHI≥5 from the diagnostic night * ≥18 years of age * Prescribed CPAP or Bilevel therapy for OSA * Existing CPAP mask users

Exclusion criteria

* Inability to give informed consent * Patient intolerant to PAP * Anatomical or physiological conditions making PAP therapy inappropriate * History of respiratory disease or CO2 retention. * Pregnant or think they may be pregnant * Investigated by Land Transport Safety Authority

Design outcomes

Primary

MeasureTime frameDescription
Participants perception of the headgear on mask performance2-4 weeksAssess if the headgear with mask changes the perception of the performance of the mask.

Secondary

MeasureTime frameDescription
Number of participants that choose this Headgear over their usual.2-4 weeksAssess the acceptability of the headgear with mask.

Countries

New Zealand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026